[(2,2-Dimethylpropanoyl)oxy]methyl (4R,5S,6S)-3-{[1-(4,5-dihydro-1,3-thiazol-2-yl)-3-azetidinyl]sulfanyl}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate(CAS: 161715-24-8)

This compound has a crystalline form and a molecular weight of approximately 502.59 g/mol. It is slightly soluble in water but highly soluble in organic solvents. The compound shows reactivity towards nucleophiles and bases. It is stable under normal conditions but should be handled under inert conditions to avoid decomposition.

The compound is synthesized via a multistep process involving cyclization, sulfide formation, and esterification reactions. Commonly used catalysts include Lewis acids, and the reaction conditions are optimized for high yield and selectivity. The synthesis is typically conducted under an inert atmosphere to prevent side reactions.

This compound is primarily used in the pharmaceutical industry for its potential as a therapeutic agent. It also has applications in sensor technology and as a building block for other complex molecules. Its unique chemical structure makes it suitable for various research and development efforts in these fields.

Handling this compound requires wearing appropriate personal protective equipment (PPE) such as gloves, goggles, and a lab coat. Work should be conducted in a fume hood to minimize exposure. Spills should be cleaned up immediately with appropriate absorbent materials. Always refer to the Safety Data Sheet (SDS) for detailed handling instructions and emergency procedures.